Ashkan Emadi, MD

Hematologist Oncologist, Professor of Medicine, Associate Director for Clinical Research, University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC), & Director of Translational Genomics Laboratory, University of Maryland School of Medicine (UMSOM)

location_city University Of Maryland School Of Medicine

13 years treating Acute Myeloid Leukemia

Clinical Expertise

Dr. Emadi directs cutting-edge translational patient-centered research focused on exploiting cancer metabolism particularly the glutamine dependency of cancers. His discovery of the combination of venetoclax (Ven) and pegcrisantaspase (PegC) as a novel, well tolerated and highly active regimen in vivo for the treatment of AML with a complex karyotype is potentially paradigm shifting for the treatment of poor risk AML.